SBIO ETF
ALPS Medical Breakthroughs ETF
ORKA is SBIO's largest holding at 4.43% of the fund as of Nov 3, 2026. SBIO is ALPS Medical Breakthroughs ETF.
| # | Ticker | Name | Weight | Cumulative | Shares | Mkt value | Sector | Industry |
|---|---|---|---|---|---|---|---|---|
| 1 | O | Oruka Therapeutics IncHealth Care · Biotechnology | 4.43% | 4.4% | 81,090 | $8.07M | Health Care | Biotechnology |
| 2 | C | CG Oncology IncHealth Care · Biotechnology | 3.82% | 8.3% | 108,550 | $6.95M | Health Care | Biotechnology |
| Sector and industry · Pro | ||||||||
| 3 | M | Veradermics Inc | 3.75% | 12.0% | 51,154 | $6.83M | ||
| 4 | T | Travere Therapeutics Inc | 3.13% | 15.1% | 115,422 | $5.70M | ||
| 5 | D | Dianthus Therapeutics Inc | 3.11% | 18.2% | 68,461 | $5.66M | ||
| 6 | — | Definium Therapeutics Inc | 3.02% | 21.3% | 164,509 | $5.50M | ||
| 7 | E | Edgewise Therapeutics Inc | 2.75% | 24.0% | 132,952 | $5.01M | ||
| 8 | R | Relay Therapeutics Inc | 2.57% | 26.6% | 268,304 | $4.68M | ||
| 9 | X | Xenon Pharmaceuticals Inc | 2.49% | 29.1% | 118,559 | $4.53M | ||
| 10 | A | Amylyx Pharmaceuticals Inc | 2.46% | 31.5% | 153,697 | $4.49M | ||
| 11 | A | Acadia Pharmaceuticals Inc | 2.38% | 33.9% | 210,997 | $4.34M | ||
| 12 | D | Dyne Therapeutics Inc | 2.26% | 36.2% | 228,641 | $4.13M | ||
| 13 | T | Tarsus Pharmaceuticals Inc | 2.14% | 38.3% | 53,719 | $3.90M | ||
| 14 | D | Denali Therapeutics Inc | 2.09% | 40.4% | 195,712 | $3.81M | ||
| 15 | I | Disc Medicine Inc | 2.09% | 42.5% | 46,995 | $3.81M | ||
| 16 | I | IDEAYA Biosciences Inc | 2.03% | 44.5% | 118,138 | $3.70M | ||
| 17 | V | Viridian Therapeutics Inc | 1.91% | 46.4% | 138,693 | $3.49M | ||
| 18 | M | MBX Biosciences Inc | 1.78% | 48.2% | 58,960 | $3.24M | ||
| 19 | Z | ZAI Lab Ltd ADR | 1.66% | 49.9% | 137,696 | $3.02M | ||
| 20 | N | Newamsterdam Pharma Company Nv | 1.60% | 51.5% | 146,386 | $2.91M | ||
| 21 | C | Celldex Therapeutics Inc | 1.57% | 53.0% | 96,167 | $2.86M | ||
| 22 | I | Immunome Inc | 1.55% | 54.6% | 139,095 | $2.83M | ||
| 23 | X | Xencor Inc | 1.53% | 56.1% | 91,043 | $2.79M | ||
| 24 | V | Vera Therapeutics Inc Class A | 1.49% | 57.6% | 88,257 | $2.71M | ||
| 25 | P | Palvella Therapeutics Inc | 1.48% | 59.1% | 17,647 | $2.70M | ||
| 26 | B | BioCryst Pharmaceuticals Inc | 1.47% | 60.6% | 312,871 | $2.68M | ||
| 27 | L | Lakefront Biotherapeutics Sponsored Adr (1 Ads : 1 Ordinary) | 1.44% | 62.0% | 81,565 | $2.62M | ||
| 28 | V | Vericel Corp | 1.41% | 63.4% | 62,712 | $2.58M | ||
| 29 | S | Sarepta Therapeutics Inc | 1.32% | 64.7% | 129,329 | $2.40M | ||
| 30 | A | Agios Pharmaceuticals Inc | 1.25% | 66.0% | 73,086 | $2.28M | ||
| 31 | Z | Zenas Biopharma Inc | 1.24% | 67.2% | 79,824 | $2.27M | ||
| 32 | M | Maze Therapeutics Inc | 1.20% | 68.4% | 67,997 | $2.19M | ||
| 33 | S | SELLAS Life Sciences Group Inc | 1.20% | 69.6% | 247,255 | $2.19M | ||
| 34 | G | Generate Biomedicines Inc | 1.19% | 70.8% | 157,150 | $2.18M | ||
| 35 | S | Stoke Therapeutics Inc | 1.17% | 72.0% | 79,004 | $2.13M | ||
| 36 | N | Nuvation Bio Inc Class A | 1.11% | 73.1% | 429,905 | $2.02M | ||
| 37 | K | Kailera Therapeutics Inc | 1.10% | 74.2% | 158,715 | $2.00M | ||
| 38 | — | Immunocore Holdings Plc American Depositary Shares, Each Representing One Ordinary Share, Nominal Value ‚0.002 Per Share | 1.04% | 75.2% | 63,076 | $1.89M | ||
| 39 | — | Structure Therapeutics Inc Adr | 0.98% | 76.2% | 87,338 | $1.78M | ||
| 40 | M | Mineralys Therapeutics Inc | 0.95% | 77.2% | 108,262 | $1.73M | ||
| 41 | T | Taysha Gene Therapies Inc | 0.90% | 78.1% | 398,934 | $1.63M | ||
| 42 | L | LB Pharmaceuticals Inc | 0.87% | 78.9% | 39,487 | $1.59M | ||
| 43 | N | Nektar Therapeutics | 0.87% | 79.8% | 41,827 | $1.58M | ||
| 44 | T | Tyra Biosciences Inc | 0.86% | 80.7% | 73,056 | $1.56M | ||
| 45 | R | Rapport Therapeutics Inc | 0.82% | 81.5% | 58,747 | $1.49M | ||
| 46 | M | MannKind Corp | 0.81% | 82.3% | 393,717 | $1.47M | ||
| 47 | C | Compass Pathways Plc Adr | 0.80% | 83.1% | 169,543 | $1.46M | ||
| 48 | V | Vor Biopharma Inc | 0.79% | 83.9% | 72,431 | $1.44M | ||
| 49 | S | Spyglass Pharma Inc | 0.77% | 84.7% | 40,941 | $1.41M | ||
| 50 | S | Seaport Therapeutics Inc | 0.73% | 85.4% | 65,542 | $1.32M | ||
| More holdings · Pro | ||||||||
SBIO ETF All Holdings
SBIO holdings total 104 positions. The top 10 holdings account for 31.5% of the fund, led by Oruka Therapeutics Inc at 4.4%, CG Oncology Inc at 3.8%, Veradermics Inc at 3.8%.
SBIO portfolio concentration is moderate, with the top 10 representing 31.5% of total assets. The largest sector exposure is Health Care at 85.4%.
SBIO sectors provide a detailed breakdown. SBIO overlap shows how holdings compare to other funds in your portfolio.
SBIO ETF Holdings
104 of 104 holdings
- 1
Oruka Therapeutics Inc
ORKAHealth Care4.43% - 2
CG Oncology Inc
CGONHealth Care3.82% - 3
Veradermics Inc
MANEUnknown3.75% - 4
Travere Therapeutics Inc
TVTXHealth Care3.13% - 5
Dianthus Therapeutics Inc
DNTHHealth Care3.11% - 6
Definium Therapeutics Inc
DFTX:CAUnknown3.02% - 7
Edgewise Therapeutics Inc
EWTXHealth Care2.75% - 8
Relay Therapeutics Inc
RLAYHealth Care2.57% - 9
Xenon Pharmaceuticals Inc
XENEHealth Care2.49% - 10
Amylyx Pharmaceuticals Inc
AMLXHealth Care2.46% - 11
Acadia Pharmaceuticals Inc Common Stock Usd 0.0001
ACADHealth Care2.38% - 12
Dyne Therapeutics Inc
DYNHealth Care2.26% - 13
Tarsus Pharmaceuticals Inc
TARSHealth Care2.14% - 14
Denali Therapeutics Inc
DNLIHealth Care2.09% - 15
Disc Medicine Inc
IRONHealth Care2.09% - 16
IDEAYA Biosciences Inc
IDYAHealth Care2.03% - 17
Viridian Therapeutics Inc
VRDNHealth Care1.91% - 18
MBX Biosciences Inc
MBXHealth Care1.78% - 19
ZAI Lab Ltd ADR
ZLABHealth Care1.66% - 20
Newamsterdam Pharma Company Nv
NAMSHealth Care1.60% - 21
Celldex Therapeutics Inc
CLDXHealth Care1.57% - 22
Immunome Inc
IMNMHealth Care1.55% - 23
Xencor Inc
XNCRHealth Care1.53% - 24
Vera Therapeutics Inc Class A
VERAHealth Care1.49% - 25
Palvella Therapeutics Inc
PVLAHealth Care1.48% - 26
BioCryst Pharmaceuticals Inc
BCRXHealth Care1.47% - 27
Lakefront Biotherapeutics Sponsored Adr (1 Ads : 1 Ordinary)
GLPG:BRHealth Care1.44% - 28
Vericel Corp
VCELHealth Care1.41% - 29
Sarepta Therapeutics Inc
SRPTHealth Care1.32% - 30
Agios Pharmaceuticals Inc
AGIOHealth Care1.25% - 31
Zenas Biopharma Inc
ZBIOHealth Care1.24% - 32
Maze Therapeutics Inc
MAZEHealth Care1.20% - 33
SELLAS Life Sciences Group Inc
SLSHealth Care1.20% - 34
Generate Biomedicines Inc
GENBUnknown1.19% - 35
Stoke Therapeutics Inc
STOKHealth Care1.17% - 36
Nuvation Bio Inc Class A
NUVBHealth Care1.11% - 37
Kailera Therapeutics Inc
KLRAUnknown1.10% - 38
Immunocore Holdings Plc American Depositary Shares, Each Representing One Ordinary Share, Nominal Value ‚0.002 Per Share
IMCR:LNHealth Care1.04% - 39
Structure Therapeutics Inc Adr
GPCR:SHHealth Care0.98% - 40
Mineralys Therapeutics Inc
MLYSHealth Care0.95% - 41
Taysha Gene Therapies Inc
TSHAHealth Care0.90% - 42
LB Pharmaceuticals Inc
LBRXUnknown0.87% - 43
Nektar Therapeutics
NKTRHealth Care0.87% - 44
Tyra Biosciences Inc
TYRAHealth Care0.86% - 45
Rapport Therapeutics Inc
RAPPHealth Care0.82% - 46
MannKind Corp
MNKDHealth Care0.81% - 47
Compass Pathways Plc Adr
CMPSHealth Care0.80% - 48
Vor Biopharma Inc
VORUnknown0.79% - 49
Spyglass Pharma Inc
SGPUnknown0.77% - 50
Seaport Therapeutics Inc
SPTXUnknown0.73% - 51
Immatics N.V. Ordinary Shares
4A3:BEHealth Care0.71% - 52
Rigel Pharmaceuticals Inc
RIGLHealth Care0.61% - 53
MeiraGTx Holdings PLC
MGTX:KYHealth Care0.61% - 54
Alto Neuroscience Inc Class C
ANROHealth Care0.60% - 55
Kura Oncology Inc
KURAHealth Care0.59% - 56
Corvus Pharmaceuticals Inc
CRVSHealth Care0.56% - 57
Wave Life Sciences Inc
WVEUnknown0.47% - 58
Candel Therapeutics Inc
CADLHealth Care0.45% - 59
Solid Biosciences Inc
SLDBHealth Care0.45% - 60
4D Molecular Therapeutics Inc
FDMTHealth Care0.44% - 61
ArriVent Biopharma Inc
AVBPHealth Care0.43% - 62
Design Therapeutics Inc
DSGNHealth Care0.43% - 63
Olema Pharmaceuticals Inc
OLMAHealth Care0.43% - 64
Bicara Therapeutics Inc
BCAXHealth Care0.40% - 65
Geron Corp
GERNHealth Care0.40% - 66
Eliem Therapeutics Inc
ELYMHealth Care0.38% - 67
Aclaris Therapeutics Inc
ACRSHealth Care0.37% - 68
Fulgent Genetics Inc
FLGTHealth Care0.36% - 69
NEURogene
NGNEUnknown0.36% - 70
Delcath Systems Inc
DCTHHealth Care0.33% - 71
Oculis Holding Ag Ordinary Shares
OCS:SMUnknown0.32% - 72
Relmada Therapeutics Inc
RLMDHealth Care0.30% - 73
Allogene Therapeutics Inc
ALLOHealth Care0.26% - 74
Altimmune Inc
ALTHealth Care0.26% - 75
C4 Therapeutics Inc
CCCCHealth Care0.26% - 76
Rezolute Inc Pipe Deal Rzlt
RZLTHealth Care0.26% - 77
Tectonic Therapeutic Inc
TECXHealth Care0.25% - 78
Zura Bio Ltd Class A
ZURA:KYUnknown0.25% - 79
AgomAb Therapeutics NV Each ADS represents one common share
AGMB:BRUnknown0.22% - 80
Contineum Therapeutics Inc Class A
CTNMHealth Care0.21% - 81
X4 Pharmaceuticals, Inc.
XFORHealth Care0.21% - 82
Eikon Therapeutics Inc
EIKNUnknown0.20% - 83
Enanta Pharmaceuticals Inc
ENTAHealth Care0.20% - 84
Fulcrum Therapeutics Inc Com
FULCHealth Care0.19% - 85
Sab Biotherapeutics, Inc.
SABSHealth Care0.19% - 86
Arcturus Therapeutics Holdings Inc.
ARCTUnknown0.18% - 87
Immuneering Corp.
IMRXHealth Care0.16% - 88
Evommune Inc
EVMNUnknown0.14% - 89
Inhibikase Thera
IKTHealth Care0.14% - 90
Akebia Therapeutics Inc
AKBAHealth Care0.13% - 91
Bicycle Therapeutics Plc-Adr
BCYC:LNHealth Care0.12% - 92
Upstream Bio Inc
UPBHealth Care0.12% - 93
Sionna Therapeutics Inc
SIONHealth Care0.11% - 94
Macrogenics Inc
MGNXHealth Care0.10% - 95
Compass Therapeutics Inc
CMPXHealth Care0.09% - 96
Protara Therapeutics Inc
TARAHealth Care0.09% - 97
I Mab ADR
IMABUnknown0.08% - 98
Anavex Life Scienc Com New
AVXLHealth Care0.07% - 99
Immunic Inc.
IMUXUnknown0.07% - 100
Tenax Therapeutics Inc
TENXUnknown0.05% - 101
Cash Equivalent
Other0.01% - 102
Chinook Therapeutics Inc. 12/31/2049
Other0.00% - 103
Novo Nordisk A/S 12/31/2049
Other0.00% - 104
Astrazeneca Plc 12/31/2099
Other0.00%
| # | Company | Ticker | Sector | Industry | Weight |
|---|---|---|---|---|---|
| 1 | Oruka Therapeutics Inc | ORKA | 4.430% | ||
| 2 | CG Oncology Inc | CGON | 3.820% | ||
| 3 | Veradermics Inc | MANE | 3.750% | ||
| 4 | Travere Therapeutics Inc | TVTX | 3.130% | ||
| 5 | Dianthus Therapeutics Inc | DNTH | 3.110% | ||
| 6 | Definium Therapeutics Inc | DFTX:CA | 3.020% | ||
| 7 | Edgewise Therapeutics Inc | EWTX | 2.750% | ||
| 8 | Relay Therapeutics Inc | RLAY | 2.570% | ||
| 9 | Xenon Pharmaceuticals Inc | XENE | 2.490% | ||
| 10 | Amylyx Pharmaceuticals Inc | AMLX | 2.460% | ||
| 11 | Acadia Pharmaceuticals Inc Common Stock Usd 0.0001 | ACAD | 2.380% | ||
| 12 | Dyne Therapeutics Inc | DYN | 2.260% | ||
| 13 | Tarsus Pharmaceuticals Inc | TARS | 2.140% | ||
| 14 | Denali Therapeutics Inc | DNLI | 2.090% | ||
| 15 | Disc Medicine Inc | IRON | 2.090% | ||
| 16 | IDEAYA Biosciences Inc | IDYA | 2.030% | ||
| 17 | Viridian Therapeutics Inc | VRDN | 1.910% | ||
| 18 | MBX Biosciences Inc | MBX | 1.780% | ||
| 19 | ZAI Lab Ltd ADR | ZLAB | 1.660% | ||
| 20 | Newamsterdam Pharma Company Nv | NAMS | 1.600% | ||
| 21 | Celldex Therapeutics Inc | CLDX | 1.570% | ||
| 22 | Immunome Inc | IMNM | 1.550% | ||
| 23 | Xencor Inc | XNCR | 1.530% | ||
| 24 | Vera Therapeutics Inc Class A | VERA | 1.490% | ||
| 25 | Palvella Therapeutics Inc | PVLA | 1.480% | ||
| 26 | BioCryst Pharmaceuticals Inc | BCRX | 1.470% | ||
| 27 | Lakefront Biotherapeutics Sponsored Adr (1 Ads : 1 Ordinary) | GLPG:BR | 1.440% | ||
| 28 | Vericel Corp | VCEL | 1.410% | ||
| 29 | Sarepta Therapeutics Inc | SRPT | 1.320% | ||
| 30 | Agios Pharmaceuticals Inc | AGIO | 1.250% | ||
| 31 | Zenas Biopharma Inc | ZBIO | 1.240% | ||
| 32 | Maze Therapeutics Inc | MAZE | 1.200% | ||
| 33 | SELLAS Life Sciences Group Inc | SLS | 1.200% | ||
| 34 | Generate Biomedicines Inc | GENB | 1.190% | ||
| 35 | Stoke Therapeutics Inc | STOK | 1.170% | ||
| 36 | Nuvation Bio Inc Class A | NUVB | 1.110% | ||
| 37 | Kailera Therapeutics Inc | KLRA | 1.100% | ||
| 38 | Immunocore Holdings Plc American Depositary Shares, Each Representing One Ordinary Share, Nominal Value ‚0.002 Per Share | IMCR:LN | 1.040% | ||
| 39 | Structure Therapeutics Inc Adr | GPCR:SH | 0.980% | ||
| 40 | Mineralys Therapeutics Inc | MLYS | 0.950% | ||
| 41 | Taysha Gene Therapies Inc | TSHA | 0.900% | ||
| 42 | LB Pharmaceuticals Inc | LBRX | 0.870% | ||
| 43 | Nektar Therapeutics | NKTR | 0.870% | ||
| 44 | Tyra Biosciences Inc | TYRA | 0.860% | ||
| 45 | Rapport Therapeutics Inc | RAPP | 0.820% | ||
| 46 | MannKind Corp | MNKD | 0.810% | ||
| 47 | Compass Pathways Plc Adr | CMPS | 0.800% | ||
| 48 | Vor Biopharma Inc | VOR | 0.790% | ||
| 49 | Spyglass Pharma Inc | SGP | 0.770% | ||
| 50 | Seaport Therapeutics Inc | SPTX | 0.730% | ||
| 51 | Immatics N.V. Ordinary Shares | 4A3:BE | 0.710% | ||
| 52 | Rigel Pharmaceuticals Inc | RIGL | 0.610% | ||
| 53 | MeiraGTx Holdings PLC | MGTX:KY | 0.610% | ||
| 54 | Alto Neuroscience Inc Class C | ANRO | 0.600% | ||
| 55 | Kura Oncology Inc | KURA | 0.590% | ||
| 56 | Corvus Pharmaceuticals Inc | CRVS | 0.560% | ||
| 57 | Wave Life Sciences Inc | WVE | 0.470% | ||
| 58 | Candel Therapeutics Inc | CADL | 0.450% | ||
| 59 | Solid Biosciences Inc | SLDB | 0.450% | ||
| 60 | 4D Molecular Therapeutics Inc | FDMT | 0.440% | ||
| 61 | ArriVent Biopharma Inc | AVBP | 0.430% | ||
| 62 | Design Therapeutics Inc | DSGN | 0.430% | ||
| 63 | Olema Pharmaceuticals Inc | OLMA | 0.430% | ||
| 64 | Bicara Therapeutics Inc | BCAX | 0.400% | ||
| 65 | Geron Corp | GERN | 0.400% | ||
| 66 | Eliem Therapeutics Inc | ELYM | 0.380% | ||
| 67 | Aclaris Therapeutics Inc | ACRS | 0.370% | ||
| 68 | Fulgent Genetics Inc | FLGT | 0.360% | ||
| 69 | NEURogene | NGNE | 0.360% | ||
| 70 | Delcath Systems Inc | DCTH | 0.330% | ||
| 71 | Oculis Holding Ag Ordinary Shares | OCS:SM | 0.320% | ||
| 72 | Relmada Therapeutics Inc | RLMD | 0.300% | ||
| 73 | Allogene Therapeutics Inc | ALLO | 0.260% | ||
| 74 | Altimmune Inc | ALT | 0.260% | ||
| 75 | C4 Therapeutics Inc | CCCC | 0.260% | ||
| 76 | Rezolute Inc Pipe Deal Rzlt | RZLT | 0.260% | ||
| 77 | Tectonic Therapeutic Inc | TECX | 0.250% | ||
| 78 | Zura Bio Ltd Class A | ZURA:KY | 0.250% | ||
| 79 | AgomAb Therapeutics NV Each ADS represents one common share | AGMB:BR | 0.220% | ||
| 80 | Contineum Therapeutics Inc Class A | CTNM | 0.210% | ||
| 81 | X4 Pharmaceuticals, Inc. | XFOR | 0.210% | ||
| 82 | Eikon Therapeutics Inc | EIKN | 0.200% | ||
| 83 | Enanta Pharmaceuticals Inc | ENTA | 0.200% | ||
| 84 | Fulcrum Therapeutics Inc Com | FULC | 0.190% | ||
| 85 | Sab Biotherapeutics, Inc. | SABS | 0.190% | ||
| 86 | Arcturus Therapeutics Holdings Inc. | ARCT | 0.180% | ||
| 87 | Immuneering Corp. | IMRX | 0.160% | ||
| 88 | Evommune Inc | EVMN | 0.140% | ||
| 89 | Inhibikase Thera | IKT | 0.140% | ||
| 90 | Akebia Therapeutics Inc | AKBA | 0.130% | ||
| 91 | Bicycle Therapeutics Plc-Adr | BCYC:LN | 0.120% | ||
| 92 | Upstream Bio Inc | UPB | 0.120% | ||
| 93 | Sionna Therapeutics Inc | SION | 0.110% | ||
| 94 | Macrogenics Inc | MGNX | 0.100% | ||
| 95 | Compass Therapeutics Inc | CMPX | 0.090% | ||
| 96 | Protara Therapeutics Inc | TARA | 0.090% | ||
| 97 | I Mab ADR | IMAB | 0.080% | ||
| 98 | Anavex Life Scienc Com New | AVXL | 0.070% | ||
| 99 | Immunic Inc. | IMUX | 0.070% | ||
| 100 | Tenax Therapeutics Inc | TENX | 0.050% | ||
| 101 | Cash Equivalent | - | 0.010% | ||
| 102 | Chinook Therapeutics Inc. 12/31/2049 | - | 0.000% | ||
| 103 | Novo Nordisk A/S 12/31/2049 | - | 0.000% | ||
| 104 | Astrazeneca Plc 12/31/2099 | - | 0.000% |














































